Skin cancer is worldwide the most frequently diagnosed cancer with highly growing yearly numbers. DermoScan occupies with its medical imaging systems the area of monitoring and differential diagnostics in skin cancer (skin cancer screening) and sets here new trends in preventive and risk diagnostics. With DermoScan you are investing in a reliable team with long ongoing experience in the field of medical imaging systems. Leading in the field in technology, mobility and flexibility, our dermoscopy systems are tailored to the requirements of the future. The user friendly and highly precise products enable quick and reliable diagnostics. This guarantees an optimum in diagnostic security, efficient workflow and economical attractiveness. We will steadily build up our product portfolio together with dermatologists and scientists, to develop and market ergonomical useful products, utilizing new and established methods and technologies. Our Credo: - Simple and intuitive handling - Time saving procedures - HighTech at attractive prices
Looking for a particular Dermoscan GmbH employee's phone or email?
The Dermoscan GmbH annual revenue was $7 million in 2026.
Johann Tillmann is the Managing Director of Dermoscan GmbH.
7 people are employed at Dermoscan GmbH.
Dermoscan GmbH is based in Regensburg, Bavaria.
The NAICS codes for Dermoscan GmbH are [423, 42391, 4239, 42, 423910].
The SIC codes for Dermoscan GmbH are [51, 513].